Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.

Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.

A nascent but growing consumer market for brain-computer interface technology is driving the development of sleek new tools for decoding brain activity.

Advice for new principal investigators starting their first research laboratories!

The California-based company Humm has developed a “bioelectric memory patch” to improve working memory, but some experts question the efficacy of the device.

In a small trial of deceased volunteers, a Seattle-based company called Recompose demonstrates that its method for “natural organic reduction” of a human body completely breaks down soft tissue.

The midwestern state has quietly laid the groundwork for a biotech hub.

The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.

The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.

A device implanted into mice can modulate brain circuit activity over long periods of time.

Unlike biotech tools adapted from nature, the invention was entirely conceived by humans and represents one of the few proteins made from scratch in the lab.

Executives at a biotech that develops new antibodies argue that Ram Sasisekharan didn’t come up with the structures for at least two experimental therapies that his group has described.

The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.

Deep-learning algorithms could help doctors narrow in on the causes of certain medical conditions, say researchers.

The documentary weaves together a hunt for mammoth tusks in the Arctic with scenes from the front lines of synthetic biology.

The country is the second in Africa to permit cannabis cultivation, but months after approval there’s been little uptake by farmers and no scientific proposals.

The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.

In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.

Biotech stocks fell in response to the news.